Literature DB >> 12167377

The management of hyperuricemia and gout in patients with heart failure.

Lukas E Spieker1, Frank T Ruschitzka, Thomas F Lüscher, Georg Noll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12167377     DOI： 10.1016/s1388-9842(02)00086-7

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  9 in total

1.  A New Clinically Applicable Measure of Functional Status in Patients With Heart Failure: The 60-Foot Walk Test.

Authors:  Kristie M Harris; David S Krantz; Willem J Kop; Joanne Marshall; Shawn W Robinson; Jennifer M Marshall; Stephen S Gottlieb
Journal:  JACC Heart Fail       Date:  2017-05-10       Impact factor: 12.035

Review 2.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 3.  Management of hyperuricemia in gout: focus on febuxostat.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

Review 4.  Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.

Authors:  John S Bomalaski; Mike A Clark
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

5.  Spinal and sacroiliac gouty arthritis: report of a case and review of the literature.

Authors:  Fabiano Nassar Cardoso; Patrick Omoumi; Gregoire Wieers; Baudouin Maldague; Jacques Malghem; Frédéric E Lecouvet; Bruno C Vande Berg
Journal:  Acta Radiol Short Rep       Date:  2014-09-17

6.  Association of hyperuricemia with apolipoprotein AI and atherogenic index of plasma in healthy Chinese people: a cross-sectional study.

Authors:  Yan Duan; Xiaona Chang; Xiaoyu Ding; Yu An; Guang Wang; Jia Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-08-15       Impact factor: 2.174

7.  Determination of uric acid level by polyaniline and poly (allylamine): Based biosensor.

Authors:  Nasrul Wathoni; Aliya Nur Hasanah; Dolih Gozali; Yeni Wahyuni; Lia Layusa Fauziah
Journal:  J Adv Pharm Technol Res       Date:  2014-01

8.  Increased the risk of heart failure and comorbidities in patients with gout treatment: a population-based cohort study.

Authors:  Hsin-Hung Chen; Ming-Chia Hsieh; Chun-Wei Ho; Ching-Chu Chen; Sheng-Pang Hsu; Shih-Sheng Chang; Cheng-Li Lin; Chia-Hung Kao
Journal:  Ann Transl Med       Date:  2020-04

9.  Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF.

Authors:  Kirsty McDowell; Paul Welsh; Kieran F Docherty; David A Morrow; Pardeep S Jhund; Rudolf A de Boer; Eileen O'Meara; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Ann Hammarstedt; Anna Maria Langkilde; Mikaela Sjöstrand; Daniel Lindholm; Scott D Solomon; Naveed Sattar; Marc S Sabatine; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2022-02-06       Impact factor: 17.349
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.